Skip to content

Drug interactions

Disopyramide + Nilotinib

Severity: Contraindicated

Disopyramide and Nilotinib: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents prolong the QT interval, and concurrent use increases the risk of torsades de pointes and sudden death. Disopyramide also has proarrhythmic potential in its own right.

What this interaction means in plain words

Disopyramide and Nilotinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Disopyramide belongs to Cardiovascular; Nilotinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive prolongation of cardiac repolarization (QT interval).

What to do

Avoid concurrent use and choose a non-QT-prolonging antiarrhythmic. Correct electrolytes and monitor ECG if no alternative exists.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Disopyramide and Nilotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Disopyramide with Nilotinib?

MediHelp rates the interaction as contraindicated. Disopyramide and Nilotinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Both agents prolong the QT interval, and concurrent use increases the risk of torsades de pointes and sudden death. Disopyramide also has proarrhythmic potential in its own right.

How serious is the interaction between Disopyramide and Nilotinib?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use and choose a non-QT-prolonging antiarrhythmic. Correct electrolytes and monitor ECG if no alternative exists.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Dofetilide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in